par Desmedt, Christine 
;Salgado, Roberto;Fornili, Marco;Pruneri, Giancarlo;Van den Eynden, Gert;Zoppoli, Gabriele;Rothé, Françoise ;Buisseret, Laurence ;Garaud, Soizic ;Willard-Gallo, Karen ;Brown, David;Bareche, Yacine ;Rouas, Ghizlane;Galant, Christine;Bertucci, François;Loi, Sherene ;Viale, Giuseppe;Di Leo, Angelo ;Green, Andrew R;Ellis, Ian O;Rakha, Emad EA;Larsimont, Denis ;Biganzoli, Elia;Sotiriou, Christos
Référence Journal of the National Cancer Institute
Publication Publié, 2018-02-10
;Salgado, Roberto;Fornili, Marco;Pruneri, Giancarlo;Van den Eynden, Gert;Zoppoli, Gabriele;Rothé, Françoise ;Buisseret, Laurence ;Garaud, Soizic ;Willard-Gallo, Karen ;Brown, David;Bareche, Yacine ;Rouas, Ghizlane;Galant, Christine;Bertucci, François;Loi, Sherene ;Viale, Giuseppe;Di Leo, Angelo ;Green, Andrew R;Ellis, Ian O;Rakha, Emad EA;Larsimont, Denis ;Biganzoli, Elia;Sotiriou, Christos Référence Journal of the National Cancer Institute
Publication Publié, 2018-02-10
Article révisé par les pairs
| Résumé : | Invasive lobular breast cancer (ILC) is the second most common histological subtype of breast cancer after invasive ductal cancer (IDC). Here, we aimed at evaluating the prevalence, levels, and composition of tumor-infiltrating lymphocytes (TILs) and their association with clinico-pathological and outcome variables in ILC, and to compare them with IDC. |
